RPRX Financial Facts
General and administrative: 997KLoss per share - basic and diluted:: -0.17
See Full Income Statement
Prepaid expenses and other current assets: 158K
Commitments and contingencies (note 5): 0
See Full Balance Sheet
Repros Therapeutics Inc. (RPRX) Earnings
|
Expand Research on RPRX
| Next EPS Date | 5/2/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -46.3% | Revenue Growth Rate | -2.1% |
| Average % Move 1-Wk after EPS | +3.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/2/24  |
Q124 | N/A | $0.98 | N/A | N/A | $669.57M | N/A | N/A | N/A | ||
| 2/15/24 |
Q423 | N/A | $0.97 | N/A | N/A | $664.45M | N/A | N/A | N/A | ||
| 11/8/23 |
Q323 | N/A | $0.77 | N/A | N/A | $629.02M | N/A | N/A | N/A | ||
| 8/8/23 |
Q223 | N/A | $0.83 | N/A | N/A | $544.1M | N/A | N/A | N/A | ||
| 5/9/23 | Q123 | $0.00 | $1.15 | -$1.15 | $684M | $806.84M | N/A |  | | Details | |
| 2/15/23 | Q422 | N/A | $1.47 | N/A | N/A | $1.05B | = | N/A | N/A | ||
| 11/8/22 | Q322 | $0.00 | $0.71 | -$0.71 | $573M | $584.92M | = | | | Details | |
| 8/4/22 | Q222 | $0.00 | N/A | N/A | $536M | $532.56M | = | | | Details |
